HOME PAGE
 
HOME PAGE

SeniorHealthWeek
Acid Reflux
Alzheimer's
Arthritis
Bladder Control
Breast Cancer
Cholesterol
Colorectal Cancer
Depression
Diabetes
Eye Disease
Heart Disease
Hypertension
Joint Replacement
Lung Cancer
Menopause
Osteoporosis
Parkinsons
Prostate Cancer
Skin Cancer
Senior Health Report: Diabetes
Health News You Can Use •

Diabetes News:

Study: Two Drugs With Insulin Are Better Than One for Avoiding Weight Gain


Two drugs combined with insulin are better than one in regulating the blood-sugar levels of type 2 diabetics without the common side effect of weight gain, according to a study reported in the July issue of Diabetes Care.

Type 2 diabetics being treated with drugs typically take insulin and only one of the drugs. Such patients often lower their blood sugar below the 7 percent limit suggested by the American Diabetes Association, but they also tend to gain weight and to increase their insulin doses.

University of Texas Southwestern Medical Center researchers say they are the first to analyze the safety and effectiveness of triple therapy using insulin, metformin and a drug in the thiazolidinedione family.

"We've shown spectacular control of blood sugar levels in the absence of weight gain, a common side effect of drug therapies for type 2 diabetes," said study author Dr. Philip Raskin, a UT Southwestern professor of internal medicine. "And we can keep the blood sugar under control with relative ease. This is a step in the right direction for effectively treating type 2 diabetes."

In the UT Southwestern study, all 28 patients who used triple therapy reduced their blood-sugar levels below 7 percent without increasing insulin. Patients who took the therapy in a particular order, with the thiazolidinedione administered after a period of insulin and metformin use, actually showed a slight decrease in weight, along with lowering blood sugar.

Almost 60 percent of all patients, regardless of what order the drugs were taken, reduced blood sugar levels below 6 percent.

Keeping blood-sugar levels under 6 percent or 7 percent significantly reduces the risk of eye disease, kidney disease and amputations, said lead researcher Suzanne Strowig, a UT Southwestern faculty member.

Drugs like metformin and those in the thiazolidinedione family help the body regulate the amount of glucose in the blood and decrease the amount of glucose made by the liver. They also help the body more effectively use its own insulin, according to the researchers.

"With many of these drugs, though, people have been unable to control their weight," Raskin said. "But put together, especially in a particular order, they show the most promise."

Source: Diabetes Week staff, July 19, 2004

 

About This Site
Privacy Policy
Advertising Policy
Contact Us

USE OF THIS SITE SIGNIFIES ACCEPTANCE OF THIS USER AGREEMENT: The information provided in this and our other sites is for educational purposes only, and it is not intended nor implied to be a substitute for professional medical advice. Always consult your own physician or healthcare provider with any questions you may have regarding a medical condition. Hypertext links to other sites are for the convenience of our Web site viewers and do not constitute any endorsement. We are not responsible for the content of linked sites in any way. This site is intended for personal use only and may not be used for any commercial purpose.